Publication
MicroRNA‐181a restricts human γδ T cell differentiation by targeting Map3k2 and Notch2
| dc.contributor.author | Gordino, Gisela | |
| dc.contributor.author | Costa‐Pereira, Sara | |
| dc.contributor.author | Corredeira, Patrícia | |
| dc.contributor.author | Alves, Patrícia | |
| dc.contributor.author | Costa, Luís | |
| dc.contributor.author | Gomes, Anita Q. | |
| dc.contributor.author | Silva‐Santos, Bruno | |
| dc.contributor.author | Ribot, Julie C. | |
| dc.date.accessioned | 2021-12-15T19:33:36Z | |
| dc.date.available | 2021-12-15T19:33:36Z | |
| dc.date.issued | 2022-01 | |
| dc.description.abstract | γδ T cells are a conserved population of lymphocytes that contributes to anti-tumor responses through its overt type 1 inflammatory and cytotoxic properties. We have previously shown that human γδ T cells acquire this profile upon stimulation with IL-2 or IL-15, in a differentiation process dependent on MAPK/ERK signaling. Here, we identify microRNA-181a as a key modulator of human γδ T cell differentiation. We observe that miR-181a is highly expressed in patients with prostate cancer and that this pattern is associated with lower expression of NKG2D, a critical mediator of cancer surveillance. Interestingly, miR-181a expression negatively correlates with an activated type 1 effector profile obtained from in vitro differentiated γδ T cells and miR-181a overexpression restricts their levels of NKG2D and TNF-α. Upon in silico analysis, we identify two miR-181a candidate targets, Map3k2 and Notch2, which we validate via overexpression coupled with luciferase assays. These results reveal a novel role for miR-181a as a critical regulator of human γδ T cell differentiation and highlight its potential for manipulation of γδ T cells in next-generation immunotherapies. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Gordino G, Costa-Pereira S, Corredeira P, Alves P, Costa L, Gomes AQ, et al. MicroRNA-181a restricts human γδ T cell differentiation by targeting Map3k2 and Notch2. EMBO Rep. 2022;23:e52234. | pt_PT |
| dc.identifier.doi | 10.15252/embr.202052234 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.21/14061 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | EMBO Press | pt_PT |
| dc.relation.publisherversion | https://www.embopress.org/doi/full/10.15252/embr.202052234 | pt_PT |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | pt_PT |
| dc.subject | Cancer | pt_PT |
| dc.subject | Effector T lymphocytes | pt_PT |
| dc.subject | miR-181a | pt_PT |
| dc.subject | microRNAs | pt_PT |
| dc.subject | γδ T cells | pt_PT |
| dc.title | MicroRNA‐181a restricts human γδ T cell differentiation by targeting Map3k2 and Notch2 | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.startPage | e52234 | pt_PT |
| oaire.citation.startPage | e52234 | pt_PT |
| oaire.citation.title | EMBO reports | pt_PT |
| oaire.citation.volume | 23 | pt_PT |
| person.familyName | Gomes | |
| person.givenName | Anita | |
| person.identifier.ciencia-id | 4B10-E015-52B7 | |
| person.identifier.orcid | 0000-0002-3348-0448 | |
| person.identifier.rid | C-3580-2014 | |
| person.identifier.scopus-author-id | 7202386033 | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isAuthorOfPublication | 2b5a3f0a-29c2-4ecd-a83f-50d0b99a4875 | |
| relation.isAuthorOfPublication.latestForDiscovery | 2b5a3f0a-29c2-4ecd-a83f-50d0b99a4875 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- MicroRNA-181a restricts human γδ T cell differentiation by targeting Map3k2 and Notch2.pdf
- Size:
- 1.48 MB
- Format:
- Adobe Portable Document Format
